RxDoctor Payments Data

Hanh Pham, NP

Family · Gulfport, MSNPI 1659931939

Payments from drug & device makers

$9,141in general payments, 2019–2025

Across 390 payments — averaging $23.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • GSK$795
  • Mallinckrodt Hospital Products Inc.$593
  • Actelion Pharmaceuticals US, Inc.$540
  • Viiv Healthcare Company$500
  • Baxter Healthcare$404
  • plus $4K from 36 others

What the payments were for

  • Food & beverage$8,81896%
  • Education$3234%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,141 in reported general payments places this provider in the 95th percentile of 3,007 family providers in Mississippi.

See all family providers in Mississippi

Medicare billing

Part B allowed, 2024
$36,542
Medicare patients
327
Services billed
582

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ActharCorticotropin12$517,252
Trelegy ElliptaFluticasone/Umeclidin/Vilanter294$294,191
Breztri AerosphereBudesonide/Glycopyr/Formoterol91$75,160
Spiriva RespimatTiotropium Bromide88$66,639
Stiolto RespimatTiotropium Br/Olodaterol Hcl78$61,926
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr37$25,000
Breo ElliptaFluticasone/Vilanterol43$22,471
SymbicortBudesonide/Formoterol Fumarate58$19,585
Albuterol Sulfate HfaAlbuterol Sulfate324$12,886
Combivent RespimatIpratropium/Albuterol Sulfate11$6,023
Varenicline Tartrate22$4,503
Fluticasone-SalmeterolFluticasone Propion/Salmeterol17$4,382
Ventolin HfaAlbuterol Sulfate42$3,690
Arnuity ElliptaFluticasone Furoate13$2,327
Levalbuterol Tartrate HfaLevalbuterol Tartrate24$2,305

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Mallinckrodt Hospital Products Inc.Acthar$593$517,25212 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Arnuity Ellipta$795$343,990387 claims
Boehringer IngelheimSpiriva Respimat, Stiolto Respimat, Combivent Respimat$226$134,588177 claims
AstraZenecaBreztri Aerosphere, Symbicort$1,874$94,745149 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,007 family providers in Mississippi.

Other family in Gulfport

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →